Stereochemistry | RACEMIC |
Molecular Formula | C23H28O6 |
Molecular Weight | 400.4648 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 3 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)CCC=C=CC[C@H]1[C@H](\C=C\[C@H](O)COC2=CC=CC=C2)[C@@H](O)CC1=O
InChI
InChIKey=PTOJVMZPWPAXER-FPXSIRDUSA-N
InChI=1S/C23H28O6/c1-28-23(27)12-8-3-2-7-11-19-20(22(26)15-21(19)25)14-13-17(24)16-29-18-9-5-4-6-10-18/h3-7,9-10,13-14,17,19-20,22,24,26H,8,11-12,15-16H2,1H3/b14-13+/t2?,17-,19-,20-,22-/m0/s1
Molecular Formula | C23H28O6 |
Molecular Weight | 400.4648 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 3 |
Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
Patents
Sample Use Guides
As evidenced by a few controlled trials in patients with gastric ulcers, treatment with enprostil 35 micrograms twice daily for 6 weeks provides ulcer healing in parallel with pain relief as effectively as cimetidine and ranitidine in a high percentage of patients (about 80% after 6 weeks).
Route of Administration:
Oral